Showing items 701–756
Modulation of HIF1-beta expression
Grant US-7799764-B2
United States of America
SMALL ACTIVATING RNA MOLECULES AND METHODS OF USE
Application WO-2006113246-A3
World Intellectual Property Organisation (WIPO)
Highly branched HK peptides as effective carriers of siRNA
Application US-7772201-B2
United States of America
iRNA agents targeted to the Rho-A gene
Grant US-7772200-B2
United States of America
Useful in the design of improved RNAi-mediating agents which allow for more exact control…
Grant US-7772203-B2
United States of America
Compositions and methods for inhibiting expression of anti-apoptotic genes
Grant US-7767802-B2
United States of America
Compositions and their uses directed to Gemin Genes
Grant US-7759479-B1
United States of America
Identification of novel pathways, genes and promoter motifs regulating adipogenesis
Grant US-7759318-B1
United States of America
Modulation of FR-alpha expression
Grant US-7754698-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
Grant US-7750144-B2
United States of America
Isolated PTPMT1 protein which mediates insulin production and uses thereof
Grant US-7749976-B2
United States of America
Modulation of apolipoprotein c-III expression
Grant US-7750141-B2
United States of America
Modulation of glucagon receptor expression
Grant US-7750142-B2
United States of America
Antisense modulation of CD40 expression
Grant US-7745609-B2
United States of America
Methods of modulating apoptosis using inhibitors of brain-localized protein kinases…
Grant US-7745164-B2
United States of America
Modulation of apolipoprotein (a) expression
Grant US-7741305-B2
United States of America
Oligonucleotide sequences for use in controlling diacylglycerol acyltransferase 2 a nd…
Grant US-7732590-B2
United States of America
Methods and compositions for controlling efficacy of RNA silencing
Grant US-7732593-B2
United States of America
Modulation of apolipoprotein (A) expression
Grant US-7723508-B2
United States of America
Compositions and methods for inhibiting expression of Eg5 gene
Grant US-7718629-B2
United States of America
Antisense modulation of kinesin-like 1 expression
Grant US-7718628-B2
United States of America
Modulation of STAT5 expression
Grant US-7709628-B2
United States of America
Use of IL-17F in diagnosis and therapy of airway inflammation
Grant US-7704503-B2
United States of America
Modulation of RANKL expression
Grant US-7700574-B2
United States of America
siRNA targeting complement factor B
Grant US-7696344-B2
United States of America
Antisense modulation of superoxide dismutase 1, soluble expression
Grant US-7678895-B2
United States of America
MICRO-RNA SCAFFOLDS, NON-NATURALLY OCCURRING MICRO-RNAS, AND METHODS FOR OPTIMIZING NON-NAT…
Application EP-2155911-A1
European Patent Office
Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
Grant US-7662796-B2
United States of America
siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)
Grant US-7655788-B2
United States of America
siRNA targeting spleen tyrosine kinase
Grant US-7645869-B2
United States of America
METHODS, COMPOSITIONS AND SYSTEMS FOR LOCAL DELIVERY OF DRUGS
Application WO-2010001325-A2
World Intellectual Property Organisation (WIPO)
Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases
Grant US-7638482-B2
United States of America
Compositions and methods for modulation of Mcl-1 expression
Grant US-7632824-B2
United States of America
Methods for slowing familial ALS disease progression
Grant US-7622455-B2
United States of America
Method of treating or ameliorating an immune cell associated pathology using GITR ligand…
Grant US-7618632-B2
United States of America
Modulation of HIF-1 beta expression
Grant US-7618947-B2
United States of America
Methods, agents, and compound screening assays for inducing differentiation of…
Grant US-7615626-B2
United States of America
siRNA targeting survivin
Grant US-7608707-B2
United States of America
Method of treating neurodegenerative disease
Grant US-7595306-B2
United States of America
Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
Application US-7585968-B2
United States of America
Compositions and methods for inhibiting expression of Nav1.8 gene
Grant US-7582745-B2
United States of America
siRNA targeting synuclein, alpha (SNCA-1)
Application US-7579458-B2
United States of America
SiRNA targeting KRAS
Grant US-7576197-B2
United States of America
COMPOSITIONS AND METHODS FOR TREATMENT OF MOOD DISORDERS
Application WO-2008020435-A3
World Intellectual Property Organisation (WIPO)
OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF CARDIOVASCULAR DISEASES
Application WO-2007029249-A3
World Intellectual Property Organisation (WIPO)
siRNA targeting KRAS
Grant US-7507811-B2
United States of America
Modulation of eIF4E-BP2 expression
Grant US-7468431-B2
United States of America
Methods and compositions for controlling efficacy of RNA silencing
Grant US-7459547-B2
United States of America
GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES…
Application WO-2008051511-A2
World Intellectual Property Organisation (WIPO)
GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
Application WO-2008033239-A2
World Intellectual Property Organisation (WIPO)
COMPOSITIONS AND METHODS FOR TREATMENT OF MOOD DISORDERS
Application WO-2008020435-A2
World Intellectual Property Organisation (WIPO)
METHOD OF PREPARING siRNAs FOR SELECTIVE INHIBITION OF TARGET mRNA ISOTYPES
Application WO-2007145458-A1
World Intellectual Property Organisation (WIPO)
A METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS, USE OF SNAIL-ACTIVITY-INHIBITING…
Application WO-2007082967-A1
World Intellectual Property Organisation (WIPO)
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS…
Application WO-2007035953-A2
World Intellectual Property Organisation (WIPO)
METHOD OF INHIBITING EXPRESSION OF TARGET MRNA USING SIRNA CONSISTING OF NUCLEOTIDE…
Application WO-2006062369-A1
World Intellectual Property Organisation (WIPO)
Showing items 701–756